Table 1.
3-phosphoglycerate → 3-phosphohydroxypyravate | oxaloacetate → malate | α-ketoglutarate → 2-hydroxyglutarate | ||||||
---|---|---|---|---|---|---|---|---|
Kcat (1/min) | 4.5 ± 0.6 | Kcat (1/min) | 10.6 ± 1.6 | Kcat (1/min) | 4.7 ± 0.9 | |||
Km, 3-phosphoglycerate (mM) | 0.26 ± 0.034 | Km, oxaloacetate (mM) | 6.5 ± 1.3 | Km, α-ketoglutarate (mM) | 10.1 ± 1.8 | |||
[3-phosphoglycerate] (mM) | MDA-MB-468 | 0.18 ± 0.01 | [oxaloacetate] (mM) | MDA-MB-468 | not detectable | [α-ketoglutarate] (mM) | MDA-MB-468 | 0.55 ± 0.02 |
BT20 | 0.11 ± 0.01 | BT20 | not detectable | BT20 | 0.47 ± 0.02 | |||
[3-phosphohydroxypyruvate] (mM) | MDA-MB-468 | not detectable | [malate] (mM) | MDA-MB-468 | 3.3 ± 0.08 | [2-hydroxyglutarate] (mM) | MDA-MB-468 | 0. 093 ± 0.009 |
BT20 | not detectable | BT20 | 0.99 ± 0.07 | BT20 | 0.035 ± 0.002 | |||
Km, NAD+ (mM) | 0.022 ± 0.003 | Km, NADH (mM) | 0.004 + 0.001 | Km, NADH (mM) | 0.004 ± 0.001 | |||
[NAD+] (mM) | MDA-MB-468 | 0.99 ± 0.01 | [NADH] (mM) | MDA-MB-468 | 0.37 ± 0.02 | [NADH] (mM) | MDA-MB-468 | 0.37 ± 0.02 |
BT20 | 0.77 ± 0.02 | BT20 | 0.186 ± 0.001 | BT20 | 0.186 ± 0.001 | |||
[NADH] (mM) | MDA-MB-468 | 0.37 ± 0.02 | [NAD+] (mM) | MDA-MB-468 | 0.99 ± 0.01 | [NAD+] (mM) | MDA-MB-468 | 0.99 ± 0.01 |
BT20 | 0.186 ± 0.001 | BT20 | 0.77 ± 0.02 | BT20 | 0.77 ± 0.02 |